A state-of-the-art triple-hormone receptor agonist peptide (targeting GLP-1, GIP, and Glucagon receptors).
Suppresses appetite, delays gastric emptying, and uniquely upregulates baseline metabolic energy expenditure for bariatric-surgery-level fat reduction.
Titrated upward strictly over a 12-to-16-week cycle, it is heavily paired with extreme high-protein intake (1g per pound of body weight) and heavy resistance training to prevent catastrophic muscle wasting.